• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Al-Azhar Journal of Pharmaceutical Sciences
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 63 (2021)
Issue Issue 1
Volume Volume 62 (2020)
Volume Volume 61 (2020)
Volume Volume 60 (2019)
Volume Volume 59 (2019)
Volume Volume 58 (2018)
Volume Volume 57 (2018)
Volume Volume 56 (2017)
Volume Volume 55 (2017)
Volume Volume 54 (2016)
Volume Volume 53 (2016)
Volume Volume 52 (2015)
Volume Volume 51 (2015)
Volume Volume 50 (2014)
Volume Volume 49 (2014)
Volume Volume 48 (2013)
Volume Volume 47 (2013)
Volume Volume 46 (2012)
Volume Volume 45 (2012)
Kabil, S. (2021). CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS. Al-Azhar Journal of Pharmaceutical Sciences, 63(1), 207-223. doi: 10.21608/ajps.2021.153569
Soad Lotfy Kabil. "CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS". Al-Azhar Journal of Pharmaceutical Sciences, 63, 1, 2021, 207-223. doi: 10.21608/ajps.2021.153569
Kabil, S. (2021). 'CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS', Al-Azhar Journal of Pharmaceutical Sciences, 63(1), pp. 207-223. doi: 10.21608/ajps.2021.153569
Kabil, S. CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS. Al-Azhar Journal of Pharmaceutical Sciences, 2021; 63(1): 207-223. doi: 10.21608/ajps.2021.153569

CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS

Article 12, Volume 63, Issue 1, March 2021, Page 207-223  XML PDF (916.07 K)
Document Type: Original Article
DOI: 10.21608/ajps.2021.153569
Author
Soad Lotfy Kabilorcid
Department of clinical pharmacology, Faculty of Medicine, Zagazig University
Abstract
Cilostazol is a phosphodiesterase III inhibitor with antiplatelet and vasodilating properties. Cilostazol effectively attenuated severity of diabetic angiopathy. However, the underlying mechanisms involved in its beneficial effect against diabetic nephropathy are not fully elucidated. Type-1 diabetic rats received cilostazol (25mg/kg/day, oral for 12 weeks). Fasting blood glucose, serum lipids, renal nuclear factor κB (NF-κB) and interluckin-6 (IL-6), kidney function markers, oxidative stress parameters were examined. The plasma soluble receptor for advanced glycation end products (sRAGE) was assayed. Renal advanced glycation end products (AGEs) level was assayed. Renal histopathological study was also performed. The results showed improvement in kidney structure and function post cilostazol treatment. Furthermore, cilostazol elevated the circulating plasma sRAGE level and decreased renal AGEs, NF-κ B and IL-6 levels.  Moreover, the renal levels of reduced glutathion, superoxide dismutase and heme oxygenase-1 increased associated with reduction in malondialdehyde suggesting enriched antioxidant status in the kidney.   Conclusion, Cilostazol ameliorates diabetic renal injury which may be, in part, due to elevation of circulating plasma sRAGE, lowering of renal AGEs level and in other part the anti-inflammatory action and enhancement of the renal antioxidant status.
Keywords
Cilostazol; diabetic nephropathy; streptozotocin; soluble receptor of advanced glycation end products
Statistics
Article View: 33
PDF Download: 35
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.